(OTCBB: IAGX)
|
Imagenetix, Inc. Profile
|
|
Imagenetix, Inc. ("Imagenetix" or "the Company") develops and markets bioceutical and pharmaceutical products. Bioceuticals, which are estimated to represent a nearly $124 billion industry worldwide, entail bioactive chemicals derived from food that have a beneficial effect on health. Imagenetix's lead bioceutical product, Celadrin®, is designed to lubricate and cushion the joints, promoting comfort and flexibility. Marketed as both a softgel and a topical cream, Celadrin® is widely available in the U.S. at Walgreens, Kroger, Costco, and Walmart, among many other retail outlets. Imagenetix also distributes Celadrin® to third parties for use in private-label products and as a branded ingredient for wholesale customers. The Company's bioceutical portfolio further includes a probiotic, BioGuard™, for supporting a healthy immune system; a proprietary compound, Trisynex™, used in products for fat loss and obesity; and a delivery system, CellSorb™, being studied for its effect at increasing the body's absorption of Coenzyme Q10 (CoQ10). At present, BioGuard™ is sold through Costco and other retail outlets, such as Rite Aid. Trisynex™ is distributed as a bulk raw material. In terms of pharmaceutical development, Imagenetix is conducting preclinical studies of a pilot blend, 1-TDC, and its active compound, MA2009, which may be able to prevent and treat periodontal disease.
|
|
